StockClub

MRKR

MRKRMarker Therapeutics, Inc.$ --
Marker Therapeutics, Inc.

Marker Therapeutics, Inc.

MRKR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -100.0%
Operating Income
-4M USD
YoY +11.6%
Net Income
-3M USD
YoY +28.5%
EPS
-0.16$
YoY +60.0%

Revenue

$0
FY2024 Q2$2.4M
$2.4M
Q2
FY2024 Q3$4.3M
$4.3M
Q3
FY2024 Q4$6.6M
$6.6M
Q4
FY2025 Q1$349,104
$349,104
Q1
FY2025 Q2$1.2M
$1.2M
Q2
FY2025 Q3$2.4M
$2.4M
Q3
FY2025 Q4$2.4M
$2.4M
Q4
FY2026 Q1$0
$0
Q1
Actual
$-349,104 (-100.0%)

Net Income

$-3.2M
FY2024 Q2$-4.6M
$-4.6M
Q2
FY2024 Q3$-6.9M
$-6.9M
Q3
FY2024 Q4$-10.7M
$-10.7M
Q4
FY2025 Q1$-4.4M
$-4.4M
Q1
FY2025 Q2$-8.5M
$-8.5M
Q2
FY2025 Q3$-10.5M
$-10.5M
Q3
FY2025 Q4$-12.2M
$-12.2M
Q4
FY2026 Q1$-3.2M
$-3.2M
Q1
Actual
+$1.3M (+28.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$466,785
Est:$483,500
FY2020MISS
$466,785
FY2021
Actual:$1.2M
FY2021
$1.2M
FY2022MISS
Actual:$3.5M
Est:$9M
FY2022MISS
$3.5M
FY2023MISS
Actual:$3.3M
Est:$3.7M
FY2023MISS
$3.3M
FY2024MISS
Actual:$6.6M
Est:$8.3M
FY2024MISS
$6.6M
FY2025MISS
Actual:$0
Est:$3.1M
FY2025MISS
$0

Analyst Estimates